Our succes in integrating information into models that generate unique insights, allowing executives to make better drug development decisions, is reflected in our gold-standard research publications.

Latest publications

Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis | Immunology

Chan P et al. | qP contributors: Prohn M, Huisman J, Matzuka B | 2020| Journal| Pharmaceutical Research Link

A LYSA Phase Ib Study of Tazemetostat (EPZ-6438) Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL) With Poor Prognosis Features | Oncology

Sarkozy C et al. | qP contributors: Suttle B | 2020| Journal| Clinical Cancer Research Link

SAGE-217: A Novel GABAA Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies | CNS

Hoffmann E et al. | qP contributors: Wald J | 2020| Journal| Clinical Pharmacokinetics Link
Get in touch
Phone (US)
+1 919 6519713
Phone (EU)
+46 70722 90 35
Connect with us